Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs041250095Suspended
Open-label, single-arm trial of 5-aminolevulinic acid in breast cancer. Primary endpoint: Usefulness of photodynamic diagnosis versus gross diagnosis. Started Sep 2025; status: suspended.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs041250095.